AEROLONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aerolone, and when can generic versions of Aerolone launch?
Aerolone is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in AEROLONE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aerolone
A generic version of AEROLONE was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
Summary for AEROLONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Patent Applications: | 954 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AEROLONE at DailyMed |
US Patents and Regulatory Information for AEROLONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | AEROLONE | isoproterenol hydrochloride | SOLUTION;INHALATION | 007245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |